Please note that this was recorded in 2017. All AMPEDTM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.
AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.
Description:
The fields of Cancer Genomics and Molecular Pathology are each complex and rapidly changing, and their intersection makes our practice challenging. Supporting clinical care and clinical research in an efficient manner requires an infrastructure to provide access to relevant information and an array of tools to prioritize and present this information in a form that helps advances team goals. These presentations describe informatics approaches that support the Precision Oncology goals of cancer genomic variant effect interpretation based on prior knowledge and statistical recurrence, and on the support of clinical trial activity.
Molecular Pathology Informatics - Toolsets and Infrastructures for Supporting Clinical Trials
Mark Routbort, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interpreting the Cancer Genome: Identifying Driver Alterations and Therapeutic Options
Nikolaus Schultz, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Learning Objectives:
- Discuss two informatics challenges in Precision Oncology.
- Discuss an infrastructure element that addresses one challenge.
- Discuss an analytical tool that addresses one challenge.
Duration: 1.50 hr
Recording Date: November 17, 2017
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
